Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Maxpar Antibodies

Fluidigm has released more than 100 pathologist-verified Maxpar antibodies for use with imaging mass cytometry on the Hyperion Imaging System. The company's portfolio now includes antibodies verified for use with both formalin-fixed, paraffin-embedded and frozen tissues. Imaging mass cytometry provides visualization of complex cellular phenotypes and their relationships in the context of cancer, immuno-oncology, and immune-mediated diseases. Using the dual capability of the Hyperion Imaging System, researchers can deeply profile a wide range of samples from blood to tissues using both mass cytometry and imaging mass cytometry, Fluidigm said.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.